The following new grants were awarded to JCCC members, announced in July 2012:
Principal Investigator:
Bouchard, Louis
Sponsor Name: National Science Foundation
Award Title: In Situ Imaging of Chemically Reacting Flows
Principal Investigator: Chiou, Pei-Yu
Sponsor Name: National Science Foundation
Award Title: Optoelectronic Tweezers on Sapphire for Compact and High Throughput Fluorescence Activated Cell Sorter
Principal Investigator: Chmielowski, Bartosz
Sponsor Name: Morphotek, Inc. (Japan)
Award Title: Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel with Morab-004 in Metastatic Soft Tissue Sarcoma
Principal Investigator: Cloughesy, Timothy
Sponsor Name: American College of Radiology
Award Title: Phase II Assessment of Tumor Hypoxia in Glioblastoma Using Fmiso With PET and MRI
Principal Investigator: Crooks, Gay
Sponsor Name: American Society of Hematology
Award Title: Mechanisms Governing Hematopoiesis Versus Cardiac Fate Specification in the Embryonic Endothelium (Fellow: Amelie Hagen)
Principal Investigator: Eradat, Herbert
Sponsor Name: Abbott Laboratories (Incl. Ross Laboratories)
Award Title: Extension Study of Navitoclax (Abt-263) in Subjects With Chronic Lymphocytic Leukemia (CLL)
Principal Investigator: Graeber, Thomas
Sponsor Name: Concern Foundation
Award Title: Signaling Changes that Confer Resistance to BRAF-Targeted Melanoma Therapy
Principal Investigator: Kominski, Gerald
Sponsor Name: Children's Hospice & Palliative Care Coalition
Award Title: Effectiveness of Pediatric Palliative Care: Preliminary Findings
Principal Investigator: McCloskey, Susan
Sponsor Name: American Society for Therapeutic Radiology & Oncology
Award Title: Adaptation of the Pro-Ctcae, A Standardized Tool for Patient Toxicity Reporting, for Use In Radiation Oncology
Principal Investigator: Pajonk, Frank
Sponsor Name: NIH/National Cancer Institute
Award Title: Erythropoietin and Breast Cancer Stem Cells
Principal Investigator: Ribas, Antoni
Sponsor Name: Phase One Foundation
Award Title: Phase 1 Study of Gene Modified Immune Cells and A Ctla4 Antibody In Patients with Advanced Melanoma
Principal Investigator: Schiller, Gary
Sponsor Name: Sanofi-Aventis Group (Incl Sanofi Synthelabo, Aventis Pasteur)
Award Title: Phase II, Multicenter, Open Label, Single Arm Study of Sar302503 in Subjects Previously Treated with Ruxolitinib and with a Current Diagnosis of Intermediate-2 or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
Principal Investigator: Sheng, Ke
Sponsor Name: NIH/National Cancer Institute
Award Title: Mechanistic Model to Derive Lung Tumor Motion From Whole Surface Tracking
Principal Investigator: Teitell, Michael
Sponsor Name: NIH/National Institute of Neurological Disorders & Stroke
Award Title: RNA Import into Mitochondria and Neurodegenerative Disorders
Principal Investigator: van Dam, Robert
Sponsor Name: NIH National Institute of Biomedical Imaging & Bioengineering
Award Title: Microliter Radiosynthesizer for Producing High Specific Activity Pet Ligands
Principal Investigator: Wong, David
Sponsor Name: NIH/National Institute Of Dental And Craniofacial Research
Award Title: UCLA Dentist-Scientist and Oral Health-Researcher Training Program (R90)
Principal Investigator: Wadehra, Madhuri
Sponsor Name: NIH/National Cancer Institute
Award Title: Using Emp2 for Image Guided Drug Delivery for Breast Cancer